ABD-350
ABD-350 is an antiresorptive agent that inhibits osteoclast activity without affecting osteoblast activity and preventing ovariectomy-induced bone loss. ABD-350 inhibits NF-κB ligand-induced inhibitor of NF-κB phosphorylation, leading to osteoclast apoptosis, but has no inhibitory effect on osteoblast function, effectively preventing bone loss in ovariectomized mice, and does not inhibit parathyroid hormone-induced bone formation.
Product Specifications
CAS Number
1117772-52-7
UNSPSC
12352005
Target
NF-κB
Type
Reference compound
Related Pathways
NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/abd-350.html
Smiles
OC(CCCCCO)C1=CC=C(C(C)=C1)C2=CC=C(C=C2F)F
Molecular Formula
C19H22F2O2
Molecular Weight
320.37
References & Citations
[1]Identification of novel biphenyl carboxylic acid derivatives as novel antiresorptive agents that do not impair parathyroid hormone-induced bone formation
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-8245R-BF594-01 20 µL
Alpha casein Polyclonal Antibody, AbBy Fluor™ 594 Conjugated
Sign In for Pricing
View Details bs-8245R-BF594-02 100 µL
Alpha casein Polyclonal Antibody, AbBy Fluor™ 594 Conjugated
Sign In for Pricing
View Details 